These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 39051094)
1. Long-Term Outcomes Following Sirolimus-Coated Balloon or Drug-Eluting Stents for Treatment of In-Stent Restenosis. Wańha W; Iwańczyk S; Januszek R; Wolny R; Tomasiewicz B; Kuliczkowski W; Reczuch K; Pawlus P; Pawłowski TZ; Kuźma Ł; Kubler P; Niezgoda P; Kubica J; Gil RJ; Pawłowski TF; Gąsior M; Jaguszewski M; Wybraniec M; Witkowski A; Kowalewski M; D'Ascenzo F; Greco A; Bartuś S; Lesiak M; Grygier M; Wojakowski W; Cortese B Circ Cardiovasc Interv; 2024 Sep; 17(9):e014064. PubMed ID: 39051094 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Coronary Drug-Eluting Stent Restenosis by a Sirolimus- or Paclitaxel-Coated Balloon. Ali RM; Abdul Kader MASK; Wan Ahmad WA; Ong TK; Liew HB; Omar AF; Mahmood Zuhdi AS; Nuruddin AA; Schnorr B; Scheller B JACC Cardiovasc Interv; 2019 Mar; 12(6):558-566. PubMed ID: 30898253 [TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty. Oh PC; Suh SY; Kang WC; Lee K; Han SH; Ahn T; Shin EK Korean J Intern Med; 2016 May; 31(3):501-6. PubMed ID: 26951915 [TBL] [Abstract][Full Text] [Related]
4. Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study. Basavarajaiah S; Naganuma T; Latib A; Sticchi A; Ciconte G; Panoulas V; Chieffo A; Montorfano M; Carlino M; Colombo A Catheter Cardiovasc Interv; 2016 Oct; 88(4):522-528. PubMed ID: 26715370 [TBL] [Abstract][Full Text] [Related]
5. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation. Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620 [TBL] [Abstract][Full Text] [Related]
6. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents. Alfonso F; Pérez-Vizcayno MJ; Cuesta J; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Cequier A; Velázquez M; Moreno R; Mainar V; Domínguez A; Moris C; Molina E; Rivero F; Jiménez-Quevedo P; Gonzalo N; Fernández-Pérez C; JACC Cardiovasc Interv; 2018 May; 11(10):981-991. PubMed ID: 29798776 [TBL] [Abstract][Full Text] [Related]
7. Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial. Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; Otaegui I; Masotti M; Zueco J; Veláquez M; Sanchís J; García-Touchard A; Lázaro-García R; Moreu J; Bethencourt A; Cuesta J; Rivero F; Cárdenas A; Gonzalo N; Jiménez-Quevedo P; Fernández C; JACC Cardiovasc Interv; 2016 Jun; 9(12):1246-1255. PubMed ID: 27339840 [TBL] [Abstract][Full Text] [Related]
8. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis. Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of drug-coated balloon angioplasty in early versus late occurring drug-eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials. Koch T; Cassese S; Xhepa E; Mayer K; Tölg R; Hoppmann P; Laugwitz KL; Byrne RA; Kastrati A; Kufner S Catheter Cardiovasc Interv; 2020 Nov; 96(5):1008-1015. PubMed ID: 31789486 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis. Almalla M; Schröder J; Pross V; Marx N; Hoffmann R Catheter Cardiovasc Interv; 2014 May; 83(6):881-7. PubMed ID: 23765557 [TBL] [Abstract][Full Text] [Related]
11. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis. Xu B; Qian J; Ge J; Wang J; Chen F; Chen J; Wei M; Chen Y; Yang Y; Gao R; Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():624-9. PubMed ID: 26775079 [TBL] [Abstract][Full Text] [Related]
12. The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis): Angiographic Results and 1-Year Clinical Outcomes. Verheye S; Vrolix M; Kumsars I; Erglis A; Sondore D; Agostoni P; Cornelis K; Janssens L; Maeng M; Slagboom T; Amoroso G; Jensen LO; Granada JF; Stella P JACC Cardiovasc Interv; 2017 Oct; 10(20):2029-2037. PubMed ID: 28964764 [TBL] [Abstract][Full Text] [Related]
13. Drug-Eluting Balloons Versus Everolimus-Eluting Stents for In-Stent Restenosis: A Meta-Analysis of Randomized Trials. Elgendy IY; Mahmoud AN; Elgendy AY; Mojadidi MK; Elbadawi A; Eshtehardi P; Pérez-Vizcayno MJ; Wayangankar SA; Jneid H; David Anderson R; Alfonso F Cardiovasc Revasc Med; 2019 Jul; 20(7):612-618. PubMed ID: 30126824 [TBL] [Abstract][Full Text] [Related]
14. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial. Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA; JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis. Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ; JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063 [TBL] [Abstract][Full Text] [Related]
16. Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: a network meta-analysis of 11 randomized, controlled trials. Lee JM; Park J; Kang J; Jeon KH; Jung JH; Lee SE; Han JK; Kim HL; Yang HM; Park KW; Kang HJ; Koo BK; Kim HS JACC Cardiovasc Interv; 2015 Mar; 8(3):382-394. PubMed ID: 25703886 [TBL] [Abstract][Full Text] [Related]
17. Long-term clinical safety and efficacy of drug-coated balloon in the treatment of in-stent restenosis: A meta-analysis and systematic review. Xi Y; Chen J; Bi Y; Xie S; Liao T; Zhang Y; Kislauskis E; Wu T; Laham R; Xiao J Catheter Cardiovasc Interv; 2020 Aug; 96(2):E129-E141. PubMed ID: 31714010 [TBL] [Abstract][Full Text] [Related]
18. Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial. Kufner S; Cassese S; Valeskini M; Neumann FJ; Schulz-Schüpke S; Hoppmann P; Fusaro M; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA; JACC Cardiovasc Interv; 2015 Jun; 8(7):877-84. PubMed ID: 26003022 [TBL] [Abstract][Full Text] [Related]
19. Bioresorbable vascular scaffold versus everolimus-eluting stents or drug eluting balloon for the treatment of coronary in-stent restenosis: 1-Year follow-up of a propensity score matching comparison (the BIORESOLVE-ISR Study). Moscarella E; Tanaka A; Ielasi A; Cortese B; Coscarelli S; De Angelis MC; Piraino D; Latib A; Grigis G; Bianchi R; Buccheri D; Calabrò P; Tespili M; Silva Orrego P; Colombo A; Varricchio A Catheter Cardiovasc Interv; 2018 Oct; 92(4):668-677. PubMed ID: 29356269 [TBL] [Abstract][Full Text] [Related]
20. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study. Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]